ESC Premium Access

No support for additional left atrial substrate modification among patients with persistent atrial fibrillation at first PVI procedure- Results from German Ablation registry

Topic: Catheter Ablation of Arrhythmias

Presentation

About the speaker

Doctor Clemens Jilek

Clinic for Internal Medicine South Munich, Munich (Germany)
2 presentations
0 follower

9 more presentations in this session

Do substrate modification in catheter ablation of atrial fibrillation increase the incidence acute complications: analysis of 10,795 procedures

Speaker: Professor Y. Murakawa (Kawasaki, JP)

Thumbnail

Role of cardioversion in the management of non-valvular atrial fibrillation: insights from the GARFIELD-AF registry

Speaker: Doctor V. Schirripa (Rome, IT)

Thumbnail

Cryoballoon versus radiofrequency ablation for atrial fibrillation - a study of outcome and safety based on the ESC-EHRA AF ablation long-term registry and the Swedish catheter ablation registry

Speaker: Professor C. Blomstrom-Lundqvist (Orebro, SE)

Thumbnail

Very long-term outcomes after a single catheter ablation procedure for the treatment of atrial fibrillation: the protective role of antiarrhythmic drug therapy

Speaker: Doctor J. Mesquita (Cambridge, GB)

Thumbnail

Long-term outcome of pulmonary vein isolation versus amiodarone therapy in patients with coexistent persistent atrial fibrillation and congestive heart failure

Speaker: Doctor S. Mohanty (Austin, US)

Thumbnail

Access the full session

Treatment of atrial fibrillation

Speakers: Doctor C. Jilek, Professor Y. Murakawa, Doctor V. Schirripa, Professor C. Blomstrom-Lundqvist, Doctor J. Mesquita...
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk